Whitehall-Robins to market softgel Advil through agreement with Scherer.
This article was originally published in The Tan Sheet
Executive Summary
WHITEHALL TO MARKET SOFTGEL ADVIL THROUGH AGREEMENT WITH SCHERER giving Whitehall-Robins the rights to market an Advil product using Scherer's patented Enhanced Solubility System (ESS). The license and supply agreement, under which Scherer is getting an undisclosed up-front payment as well as manufacturing revenues and product royalties, was announced by the companies May 6.